Both total and phosphorylated STAT1 protein was shown to be reduced in IDH1 mutant gliomas, and knockdown of STAT1 in wildtype IDH1 tumors resulted in reduced expression of these chemokines, suggesting that R-2-HG can potentially abrogate cytokine signaling through this pathway. The gene discussed is IDH1; the disease is glioma.